Patents by Inventor Michael GREVER

Michael GREVER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SILVESTROL, SILVESTROL ANALOGS AND USES THEREOF
    Publication number: 20170304261
    Abstract: Disclosed herein are treatment methods, vaccination methods, compositions, co-therapeutic methods, combination therapeutic compositions and kits comprising silvestrol and silvestrol analogs alone or in combination with therapeutic and preventative therapies. Disclosed herein are also methods, compositions and kits that can be used to treat cancer, viral infections, to modulate the immune system or as preventative therapies.
    Type: Application
    Filed: December 8, 2016
    Publication date: October 26, 2017
    Inventors: Robert A. Baiocchi, John Thomas Patton, David M. Lucas, Douglas Kinghorn, Michael Grever
  • SILVESTROL, SILVESTROL ANALOGS AND USES THEREOF
    Publication number: 20140255432
    Abstract: Disclosed herein are treatment methods, vaccination methods, compositions, co-therapeutic methods, combination therapeutic compositions and kits comprising silvestrol and silvestrol analogs alone or in combination with therapeutic and preventative therapies. Disclosed herein are also methods, compositions and kits that can be used to treat cancer, viral infections, to modulate the immune system or as preventative therapies.
    Type: Application
    Filed: July 27, 2012
    Publication date: September 11, 2014
    Applicant: OHIO STATE INNOVATION FOUNDATION
    Inventors: Robert A. Baiocchi, John Thomas Patton, JR., David M. Lucas, Douglas Kinghorn, Michael Grever
  • Dosing Regimen of Flavopiridol for Treating Cancer
    Publication number: 20110251240
    Abstract: A dosing regimen comprising a therapeutically effective amount of flavopiridol or a pharmaceutically acceptable salt thereof optionally in combination with a pharmaceutically acceptable carrier suitable for bolus infusion and subsequently for infusion is disclosed and claimed. Also disclosed and claimed is a method of treating a variety of cancers in a patient comprising administering to said patient the dosing regimen of the invention.
    Type: Application
    Filed: December 16, 2010
    Publication date: October 13, 2011
    Applicants: OHIO STATE UNIVERSITY RESEARCH FOUNDATION, AVENTIS PHARMACEUTICALS INC.
    Inventors: Jose-Ramon SUAREZ, John BYRD, Michael GREVER, James DALTON, Thomas LIN
  • Dosing Regimen of Flavopiridol for Treating Cancer`
    Publication number: 20080027105
    Abstract: A dosing regimen comprising a therapeutically effective amount of flavopiridol or a pharmaceutically acceptable salt thereof optionally in combination with a pharmaceutically acceptable carrier suitable for bolus infusion and subsequently for infusion is disclosed and claimed. Also disclosed and claimed is a method of treating a variety of cancers in a patient comprising administering to said patient the dosing regimen of the invention.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 31, 2008
    Applicants: AVENTIS PHARMACEUTICALS INC., OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Jose-Ramon SUAREZ, John BYRD, Michael GREVER, James DALTON, Thomas LIN